CCR1, 3 and 5 are known as the receptors of CCL5, and we then evaluated them in breast carcinoma tissues and examined the association between CCL5 immunoreactivity in stromal cells and clinicopathological factors according to the status of CCR1, 3 and 5 in carcinoma cells. Here, CCL5 is linked to breast carcinoma.